Organelle formation in the presence of a protease inhibitor.
D000596:Amino Acids / Q000494:pharmacology; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D002734:Chlorophyll / Q000096:biosynthesis*; D002736:Chloroplasts / Q000187:drug effects*; D003624:Darkness; D005056:Euglena gracilis / Q000166:cytology / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development* / Q000528:radiation effects; D005461:Fluorine / Q000494:pharmacology; D007700:Kinetics; D010710:Phosphates / Q000494:pharmacology; D011480:Protease Inhibitors; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011830:Radiation Effects; D013451:Sulfonic Acids / Q000494:pharmacology*
D000596:Amino Acids; D001593:Benzyl Compounds; D010710:Phosphates; D011480:Protease Inhibitors; D000644:Quaternary Ammonium Compounds; D013451:Sulfonic Acids; D002734:Chlorophyll; D005461:Fluorine